GLP-1 TV
✨NEW✨ SHOCKING insurance coverage for Zepbound/Wegovy?! New 2025 study
Today’s cheapest GLP-1$39/mo at Wellmedr, sale price.Compare all GLP-1 prices Price read 22 Nov 2026 from the seller’s own page, ranked by price alone. That price is a compounded drug, and compounded drugs are not FDA-approved. Not from the video’s creator.Our summary
The speaker covers a JP Morgan employer survey that, according to her, focused on GLP-1 coverage for the first time this year. She says the survey asked 40 top executives at large companies about their benefits. Only 45% said they currently cover GLP-1s for weight loss, while 80% cover them for type 2 diabetes. She explains the gap as a cost issue, since more people qualify under an obesity diagnosis than under type 2 diabetes, which she says would raise premiums for everyone.
Published by Brittany Rose GLP1 on YouTube
As published by the channel. Not medical advice, and not an endorsement.
What else the video covers
She reports that of the 45% covering weight loss, 65% plan to continue, and that of the companies not covering it, 13% are considering it while the rest are unsure or leaning no. She cites an October 2024 Kaiser Family Foundation analysis saying almost 50 million adults in employer plans meet clinical criteria for these drugs, which can cost thousands of dollars a year per person. She gives a rough example of 300 employees at $10,000 each, or $300,000 a year. She notes that some analysts believe Medicare coverage could push commercial plans to follow, and that Medicare currently covers Wegovy for cardiovascular benefit, with sleep apnea coverage for Zepbound expected.
The second half is mostly her opinion. She argues that even wealthy companies declining coverage suggests small employers have little chance, and that covering the drugs now could avoid later costs such as cancer treatment and joint replacements. She also criticizes the loss of compounded tirzepatide access and says she has heard of people paying about $800 or more per month even with the coupon. She asks viewers to share their thoughts.
Our summary of what is said, in our words. Doses, results and prices are the speaker’s, not advice.
Takeaways
The main points, in the order they come up. Tap a time to play from there.
- 0:30 She says JP Morgan surveyed 40 executives and only 45% report covering GLP-1s for weight loss, versus 80% for type 2 diabetes.
- 1:46 She explains the gap by saying far more people qualify for obesity than for type 2 diabetes, so coverage costs employers more.
- 3:06 She says only 65% of covering employers plan to continue, and about 13% of non-covering ones are considering it.
- 4:30 She cites a Kaiser Family Foundation estimate of almost 50 million adults in employer plans who meet criteria, with costs in the thousands per person yearly.
- 6:14 She says some analysts believe Medicare extending coverage could lead commercial insurers to follow.
- 8:14 She says Medicare currently covers Wegovy for cardiovascular benefit, with Zepbound sleep apnea coverage expected.
Key moments
Tap one to play from there.
What the video says
As stated in the video, not checked by us. Doses and results are the speaker’s, not advice.
- Medication
- Wegovy and Zepbound
Questions this video answers
What percentage of employers cover GLP-1s for weight loss?
According to the JP Morgan survey she describes, 45% of 40 surveyed executives said their companies currently cover GLP-1s for weight loss. She says 80% cover them for type 2 diabetes.
Are employers planning to drop GLP-1 weight loss coverage?
She says that of the 45% currently covering, only 65% plan to continue. Of those not covering, she reports about 13% are considering it and the rest are unsure or leaning no.
Does Medicare cover Wegovy or Zepbound?
She says Medicare currently covers Wegovy for cardiovascular benefit, and that coverage tied to Zepbound for sleep apnea should be coming. She adds that some analysts think broader Medicare coverage could influence commercial plans.
Videos on the same question
The closest videos in the library by what is said in them, not by title.
Shaquielle O'Neal Just Confirmed He's on Zepbound!This weekly news episode from the hosts of the channel covers eight GLP-1 stories.- What a GLP-1 costs at every program we trackToday’s lowest is $39/mo. Every program ranked by price alone. Compounded drugs are not FDA-approved.
How to Get Wegovy Covered | Dr. Shelly MDThe speaker, a physician, says insurance coverage is the rate-limiting step for her patients who want Wegovy or Zepbound.
Eli Lilly Just Proved GLP-1 Prices Could Be Lower… Here’s the Chart!According to the video, the speaker of the channel walks through 10 points from Eli Lilly's Q1 2026 earnings call, held April 30, 2026, and translates them for patients.
GLP-1 Drugs Are About to Destroy Medicare CostsAccording to the video, Medicare will begin covering weight loss drugs such as Wegovy and Zepbound in July 2026 through a temporary route, and the speaker argues this could change the math behind Medicare premiums.
Read next
Our guides closest to what this video covers, with prices checked weekly.
- Does Medicare cover GLP-1s? Ozempic, Wegovy and Zepbound, route by route
Yes, by two different routes. Medicare drug plans (Part D, including Medicare Advantage plans with drug coverage) cover Ozempic and Mounjaro for type 2 diabetes. For weight loss, the Medicare GLP-1 Bridge covers Wegovy (pen or pill), the Zepbound KwikPen and Foundayo for a $50 monthly copay from 1 July 2026 to 31 December 2027, if you meet CMS's BMI criteria. The catch: the Bridge runs outside Part D, so that $50 never counts toward your deductible or out-of-pocket cap.
- Does your employer cover GLP-1s for weight loss? The 2026 numbers, who dropped it, and what to do
About one large employer in five covers GLP-1s for weight loss: 19% of firms with 200 or more workers in KFF's 2025 survey, rising to 43% of firms with 5,000 or more. Among the very largest employers coverage is now falling, from 72% in 2025 to 60% in 2026 in Business Group on Health's survey, and Cigna, PwC, HCA and several state plans have dropped it. Here is who covers it, the usual conditions, and how to check your own plan.
- How to get a GLP-1 covered by insurance, in the order it actually works
There are four gates and most people fight the wrong one first. Before any clinical criterion applies, your employer has to have bought the weight-loss drug category at all, and if they did not, no BMI number and no comorbidity will change the answer. Once past that, the published criteria across the major insurers are strikingly consistent: BMI of 30 or more, or 27 with a weight-related condition, plus a documented period of lifestyle change, plus roughly 5 percent weight loss to stay approved at renewal.
Next steps
Wegovy prices
Find more like it
Dose changeCost and insuranceHow it worksThe trials
Up next
More from this collection
Watched it? See what it costs.
Every GLP-1 program we track, ranked by what actually leaves your account.




















